DreaMed Diabetes technology to be used in Medtronic insulin pump

April 6, 2015 8:08 AM

4 0

TEL AVIV, April 6 (Reuters) - Israel-based DreaMed Diabetes said on Monday it had licensed its artificial pancreas technology for integration into insulin pumps made by Medtronic .

DreaMed will receive undisclosed royalties from future sales of each device using its technology. Medtronic will be responsible for the development and marketing of the pumps.

Also read: BAT in $47 billion offer for rest of Reynolds

Read more

To category page